(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HUASHANPAI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

HUASHANPAI

ST13

US500000079013490

Class

5

Filing

79013490

Registration

3225252

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

04/04/2026

Trademark type

Combined

Nice classes

5

Filing date

07/07/2005

Registration date

04/03/2007

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/03/2016

Last transaction

04/04/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

Handan, Hebei, CN

Examiner

HAMMEL, LAURA A

Law office

M70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Handan Pharmaceutical Co., Ltd
HANDAN PHARMACEUTICAL CO., LTD.

Representatives

Tony Tune

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicines for human purposesnamely pharmaceutical preparations for the treatment of cancerdiabetesParkinson's diseaselupusmultiple sclerosisAlzheimer's diseasesenile dementiahemophiliavertigoophthalmopathyotorhinolaryngologic diseasepneumoniaemphysemarespiratory system diseasehepatitisfatty livercirrhosisChron's diseasegastritisgastric ulceralimentary system diseasenephritisurinary system infectionprostatisisarthritiscardiovascular diseasecerebrovascular disease and traumatic bleedingOral cavity ulcerdermatitis and eczema of skinMalignant neoplasm of skincalming nerves; traditional Chinese medicines for use in the treatment of insomniaheadachesdiabetescoldpharyngitisupper respiratory tract infectiongastritisgastric ulcerenteritishepatitisalimentary system diseasenephritisprostatitisurinary system infectiongenital system infectiongynopathyobesityotorhinolaryngologic diseasehypertensionhyperlipemiacardiovascular diseasecerebrovascular disease and arthritisOral cavity ulcerdermatitis and eczema of skinMalignant neoplasm of skincalming nervesloss of vitality and loss of staminastresssleep troublesdepressionpainaimed at improving hormonal balanceblood circulationslimnessdetoxicationdigestion

Publications

History of USPTO decisions and trademark events.

52 publications found

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

04/03/2026

RNWL

INTERNATIONAL REGISTRATION RENEWED

04/17/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/18/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/12/2023

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

06/03/2016

71AG

REGISTERED-SEC.71 ACCEPTED

06/03/2016

ES71

TEAS SECTION 71 RECEIVED

05/31/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/31/2016

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

04/03/2016

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

02/12/2016

RNWL

INTERNATIONAL REGISTRATION RENEWED

07/23/2015

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

11/30/2012

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

06/20/2012

71AG

REGISTERED-SEC.71 ACCEPTED

06/20/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/20/2012

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/20/2012

ES71

TEAS SECTION 71 RECEIVED

04/12/2012

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/12/2012

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/06/2008

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/27/2007

FIMP

FINAL DISPOSITION PROCESSED

09/27/2007

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/19/2007

R.PR

REGISTERED-PRINCIPAL REGISTER

04/03/2007

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

02/22/2007

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/08/2007

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

02/08/2007

PUBO

PUBLISHED FOR OPPOSITION

01/16/2007

NPUB

NOTICE OF PUBLICATION

12/27/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/27/2006

ALIE

ASSIGNED TO LIE

11/24/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/09/2006

ACEC

AMENDMENT FROM APPLICANT ENTERED

11/07/2006

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/25/2006

FAXX

FAX RECEIVED

10/25/2006

GNRT

NON-FINAL ACTION E-MAILED

10/12/2006

CNRT

NON-FINAL ACTION WRITTEN

10/12/2006

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

10/04/2006

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

09/25/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/23/2006

ALIE

ASSIGNED TO LIE

08/04/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/28/2006

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/10/2006

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/22/2006

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/22/2006

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/22/2006

RFNT

REFUSAL PROCESSED BY IB

02/17/2006

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/01/2006

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/01/2006

CNRT

NON-FINAL ACTION WRITTEN

01/31/2006

DOCK

ASSIGNED TO EXAMINER

01/26/2006

NWAP

NEW APPLICATION ENTERED

09/12/2005

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/08/2005

Continuous trademark protection

Get notified about every new filing that threatens HUASHANPAI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.